Item 2.02 Results of Operations and Financial Condition.

On May 11, 2023, Comera Life Sciences Holdings, Inc. (the "Company") announced via press release its results for the fiscal first quarter ended March 31, 2023. A copy of the Company's press release is hereby furnished to the U.S. Securities and Exchange Commission and incorporated herein by reference as Exhibit 99.1.

The information in the press release attached as Exhibit 99.1 is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing. Item 9.01. Financial Statements and Exhibits.




(d) Exhibits

Exhibit
  No.     Description

99.1        Press release dated May 11, 2023.

104       Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses